Ro Khanna sold Exelixis Inc (NASDAQ: EXEL)
Ro Khanna (D-CA), a U.S. Representative, has disclosed 1 trade in Exelixis Inc (EXEL) since 2022, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Ro Khanna sold $1,001 - $15,000 of Exelixis Inc (NASDAQ: EXEL) on December 6, 2022. Since that trade, EXEL is up +235.75% against the S&P 500 up +97.36%, an outperformance of +138.40%.
Data updated
Ro Khanna's EXEL trades vs the price
EXEL is up +235.75% since Ro Khanna sold on December 6, 2022, versus +97.36% for the S&P 500.
Performance since this trade
All Ro Khanna EXEL trades
Ro Khanna & EXEL trading FAQ
Is it legal for Ro Khanna to trade Exelixis Inc (EXEL) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Exelixis Inc (EXEL), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Ro Khanna sell EXEL?
Ro Khanna disclosed a sale of $1,001 - $15,000 of Exelixis Inc (EXEL) on December 6, 2022, according to public STOCK Act filings.
How has EXEL performed since Ro Khanna's trade?
Since Ro Khanna sold EXEL on December 6, 2022, the stock is up +235.75%, versus +97.36% for the S&P 500 over the same period, an outperformance of +138.40%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional EXEL trades?
Quantellect tracks every disclosed congressional trade in Exelixis Inc (EXEL) on the Exelixis Inc congressional trading page, which aggregates filings across all members of Congress.
Ro Khanna's EXEL tradesAll congressional filings for Exelixis IncRo Khanna's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.